Citation Impact
Citing Papers
Conformal piezoelectric energy harvesting and storage from motions of the heart, lung, and diaphragm
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Derivation and Prospective Validation of a Simple Index for Prediction of Cardiac Risk of Major Noncardiac Surgery
1999 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Energy Harvesting from the Beating Heart by a Mass Imbalance Oscillation Generator
2012
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends
2009
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Noninferiority of Closely Monitored Mechanical Valves to Bioprostheses Overshadowed by Early Mortality Benefit in Younger Patients
2012
What is the “Optimal” follow-up schedule for ICD patients?
2005
Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses
2008
Adjustable tricuspid valve annuloplasty assisted by intraoperative transesophageal color Doppler echocardiography
1993
The Failing Heart — An Engine Out of Fuel
2007 Standout
Prognostic Value of Cardiac Troponin T After Noncardiac Surgery: 6-Month Follow-Up Data 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.
1997
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
2007
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery
2009
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Mechanical Aortic Valve Replacement in Young Women Planning on Pregnancy
2012
Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
2008
Self-Management of Oral Anticoagulant Therapy: A Review
2004
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.
1993
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational study
2008
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 Standout
Myocardial Markers of Injury:Evolution and Insights
1996
Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger
2015
Cost reduction of perioperative coagulation management in cardiac surgery: value of ‘bedside’ thrombelastography (ROTEM)☆
2007
Cardiac Resynchronization and Death From Progressive Heart Failure
2003
Left ventricular systolic function in aortic stenosis
1988
Immunocytochemical localization of endothelin in cultured bovine endothelial cells
1990
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Regulation of myocardial βARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing α1B-adrenergic receptors
2001 StandoutNobel
Hypertrophic Cardiomyopathy
2002 Standout
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial
2009 Standout
Third Universal Definition of Myocardial Infarction
2012 Standout
Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain
1993
Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients
2008
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers
1999
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
2005
Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials
2004
Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis
2009
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: Results from the “LOWERING-IT” Trial
2010
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran
2011
Optimizing Timing of Surgical Correction in Patients With Severe Aortic Regurgitation: Role of Symptoms
1997
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease
1996
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Relationship Between Postoperative Cardiac Troponin I Levels and Outcome of Cardiac Surgery
2006
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Measurement and significance of circulating natriuretic peptides in cardiovascular disease
1998
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag®
2005
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
2004 Standout
Survival and Outcomes Following Bioprosthetic vs Mechanical Mitral Valve Replacement in Patients Aged 50 to 69 Years
2015
Survival and Quality of Life after Prolonged Intensive Care Unit Stay
2007
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation.
1992
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases
1999
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
2004
Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management
2005
The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
1999 StandoutNobel
Survival and Long-term Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients Aged 50 to 69 Years
2014
Mortality and Morbidity of Aortic Regurgitation in Clinical Practice
1999
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure
2011
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of W. Saggau being referenced
Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years
2007
Noninvasive assessment of coronary artery bypass patency: Determination of myocardial thallium-201 washout rates*
1988
Intraoperative transesophageal echocardiography for the evaluation of mitral, aortic and tricuspid valve repair *1A tool to optimize surgical outcome
1992
Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery
2005
Effects of solvent/detergent‐treated plasma and fresh‐frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open‐heart surgery
2002
Biventricular Pacing in Patients with ICD: How Many Patients are Possible Candidates?
2002
Low-Dose International Normalized Ratio Self-Management: A Promising Tool to Achieve Low Complication Rates After Mechanical Heart Valve Replacement
2005
Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II
2007
Komplikationen mit Sonden bei 340 Patienten mit einem implantierbaren Kardioverter/Defibrillator
1999
Cell Saver, Ultrafiltration and Direct Transfusion: Comparative Study of Three Blood Processing Techniques
2001
Survival and Quality of Life after a Long-Term Intensive Care Stay
2002
Efficacy and Safety of Very Low-Dose Self-Management of Oral Anticoagulation in Patients With Mechanical Heart Valve Replacement
2010
Reduction of Postoperative Donor Blood Requirement by Use of the Cell Separator
1985
Blood-Air Interface during Cardiopulmonary Bypass
2004
[Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].
1991
Transcription, storage and release of atrial natriuretic factor in the failing human heart
1991
INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart Valve Replacement
2003
Topical application of aprotinin in cardiac surgery
2002
Cardiodilatin-immunoreactivity in specific atrial granules of human heart revealed by the immunogold stain
1986
Myocardial catecholamine metabolism in patients with chronic aortic regurgitation.
1982
Patients with significant aortic incompetence should not be operated on until they are symptomatic.
1986
Atrial Natriuretic Peptide mRNA in Patients With Heart Disease
1990
Topische Aprotininapplikation bei kardiochirurgischen Eingriffen
2002
[Long-term prognosis of drug and surgery treated patients with acquired aortic valve diseases: survival statistics and multivariate Cox regression analysis].
1985
Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T.
1991